IGF-1 LR3 vs MOTS-c: What Is the Difference?
A folded protein that needs acid to dissolve, against a small molecule written into mitochondrial DNA. Both demanding, in unrelated ways.
In plain English
IGF-1 LR3 is a genuine protein — eighty-three amino acids folded into a specific shape — a modified growth signal altered so carrier proteins cannot capture it.
MOTS-c is a sixteen-amino-acid molecule encoded inside mitochondrial DNA, studied as a signal about a cell's energy status.
The difference, without the jargon
Both are difficult, but nothing about their difficulty overlaps. IGF-1 LR3 is fragile structurally: it has a folded shape that can come undone, will not dissolve properly in plain water, needs single-use portions because thawing damages it permanently, and — most awkwardly — shows no visible sign when ruined. Its lab report needs a test of what it actually does, because purity cannot reveal whether the shape survived. MOTS-c is fragile chemically: it contains both methionine and tryptophan, so oxygen and light attack it from two directions, and degraded material yellows visibly and shows a distinctive pattern on analysis. One warns you; the other does not.
Common questions
What is the difference between IGF-1 LR3 and MOTS-c?
IGF-1 LR3 is a folded protein studied as a growth signal. MOTS-c is a small molecule encoded in mitochondrial DNA and studied as a cellular energy signal. Different sizes, different origins, different research areas.
Why can damaged IGF-1 LR3 be hard to spot?
Because losing its folded shape does not change its weight or appearance. It looks and weighs exactly the same while being functionally inert, which is why a meaningful lab report includes a test of what it actually does.
Which needs more careful handling?
Both, differently. IGF-1 LR3 needs acidic liquid to dissolve, a protein additive to stop it sticking to containers, and single-use portions. MOTS-c needs darkness and minimal air exposure. Neither tolerates casual handling.
Technical reference below
How they actually differ
Comparing the two: IGF-1 LR3 is recombinant 83-residue protein analogue of igf-1, while MOTS-C is mitochondrial-derived peptide, 16 residues — different molecular classes with different handling consequences; they call for different primary diluents (dilute acetic acid (0.1 m) or 10 mm hcl — required for initial dissolution versus sterile or bacteriostatic water); their leading degradation routes differ (denaturation and aggregation for IGF-1 LR3, methionine oxidation to the sulfoxide (+16 da), and mots-c carries methionine at the n-terminus and internally. for MOTS-C), so the storage precautions that matter are not the same; their practical working windows differ once reconstituted. The sections below set out each in full.
IGF-1 LR3 — origin
IGF-1 LR3 is an engineered analogue carrying two changes to native IGF-1: an arginine substitution at position 3 and a 13-residue N-terminal extension. The Arg3 substitution is the functional one — it drastically reduces binding to IGF binding proteins, which normally sequester the great majority of circulating IGF-1. The result is a molecule that stays free rather than bound.
MOTS-C — origin
MOTS-c is encoded not in nuclear DNA but within the mitochondrial genome — specifically an open reading frame inside the 12S ribosomal RNA gene. Its discovery helped establish that mitochondria encode short signalling peptides that act on the rest of the cell, a genuinely recent addition to cell biology and the reason the compound attracted rapid research interest.
IGF-1 LR3 research themes
The Arg3 substitution reduces binding-protein affinity, which is the entire design rationale.
Widely used in cell-culture research as a growth-factor supplement.
Studied in muscle-biology research models.
The canonical downstream pathway examined in IGF-1 receptor research.
MOTS-C research themes
Part of a novel class demonstrating that mitochondria encode peptides acting systemically.
The most-studied signalling interaction, examined in metabolic and exercise models.
Investigated in glucose-metabolism research models.
Studies have examined MOTS-c expression in relation to physical activity and ageing in animal models.
IGF-1 LR3 handling
- Dissolve in dilute acetic acid or dilute HCl FIRST; do not attempt direct dissolution in water or PBS.
- Add carrier protein (e.g. 0.1% BSA) for storage of dilute solutions to prevent adsorptive loss.
- Prepare single-use aliquots — freeze–thaw denaturation is irreversible.
- Do not vortex; agitation denatures folded proteins at the air–liquid interface.
MOTS-C handling
- Use amber vials or wrap in foil; treat light protection as mandatory rather than precautionary.
- Minimise vial openings — headspace oxygen is the practical driver of oxidation.
- Use low-bind labware for dilute working solutions.
Both third-party tested
Every Popular Peptides batch of IGF-1 LR3 and MOTS-C is independently tested by HPLC and LC-MS with a published Certificate of Analysis. Enter a lot number to pull the COA for a specific vial.
IGF-1 LR3 reference
Related comparisons
IGF-1 LR3 and MOTS-C are supplied strictly as research chemicals for in-vitro laboratory and research use only. They are not intended for human or animal consumption, diagnostic, or therapeutic use. This comparison summarizes published preclinical literature and laboratory handling data; it is not medical advice, not a claim of efficacy, and not usage guidance.